Abstract
Helicobacter pylori infection is associated with a variety of clinical outcomes including gastric cancer and duodenal ulcer disease1. The reasons for this variation are not clear, but the gastric physiological response is influenced by the severity and anatomical distribution of gastritis induced by H. pylori. Thus, individuals with gastritis predominantly localized to the antrum retain normal (or even high) acid secretion2, whereas individuals with extensive corpus gastritis develop hypochlorhydria and gastric atrophy3, which are presumptive precursors of gastric cancer4. Here we report that interleukin-1 gene cluster polymorphisms suspected of enhancing production of interleukin-1-beta are associated with an increased risk of both hypochlorhydria induced by H. pylori and gastric cancer. Two of these polymorphism are in near-complete linkage disequilibrium and one is a TATA-box polymorphism that markedly affects DNA–protein interactions in vitro. The association with disease may be explained by the biological properties of interleukin-1-beta, which is an important pro-inflammatory cytokine5 and a powerful inhibitor of gastric acid secretion6,7. Host genetic factors that affect interleukin-1-beta may determine why some individuals infected with H. pylori develop gastric cancer while others do not.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Blaser, M. J. Helicobacter pylori and gastric diseases. Br. Med. J. 316, 1507–1510 (1998).
El-Omar, E. et al. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 109, 681–691 ( 1995).
El-Omar, E. et al. Helicobacter pylori infectin and chronic gastric acid hyposecretion. Gastroenterology 113, 15– 24 (1997).
Correa, P. Human gastric carcinogenesis: a multistep and multifactorial process—First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 52, 6735–6740 (1992).
Dinarello, C. A. Biologic basis for interleukin-1 in disease. Blood 87, 2095–2147 (1996).
Wallace, J. L., Cucala, M., Mugridge, K. & Parente, L. Secretagogue-specific effects of interleukin-1 on gastric acid secretion. Am. J. Physiol. 261, G559–G564 ( 1991).
Beales, I. L. & Calam, J. Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut 42, 227–234 (1998).
Parkin, D. M., Pisani, P. & Ferlay, J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int. J. Cancer 80, 827– 841 (1999).
Sipponen, P. Gastric cancer—a long-term consequence of Helicobactor pylori infection? Scand. J. Gastroenterol. 201, (suppl.), 24–27 (1994).
Yamaoka, Y. et al. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J. Clin. Microbiol. 37, 2274– 2279 (1999).
Hansson, L. E. et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N. Engl. J. Med. 335, 242 –249 (1996).
Kuipers, E. J. et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N. Engl. J. Med. 334, 1018– 1022 (1996).
Noach, L. A. et al. Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand. J. Gastroenterol. 29, 425– 429 (1994).
Basso, D. et al. Helicobacter pylori infection enhances mucosal interleukin-1 beta, interleukin-6, and the soluble receptor of interleukin-2. Int. J. Clin. Lab. Res. 26, 207–210 (1996).
Jung, H. C., Kim, J. M., Song, I. S. & Kim, C. Y. Helicobacter pylori induces an array of pro-inflammatory cytokines in human gastric epithelial cells: quantification of mRNA for interleukin-8, -1 alpha/beta, granulocyte-macrophage colony-stimulating factor, monocyte chemoattractant protein-1 and tumour necrosis factor-alpha. J. Gastroenterol. Hepatol. 12, 473–480 ( 1997).
Wolfe, M. M. & Nompleggi, D. J. Cytokine inhibition of gastric acid secretion—a little goes a long way. Gastroenterology 102, 2177–2178 ( 1992).
Bidwell, J. L. et al. Cytokine gene polymorphism in human disease: on-line databases. 〈http://www.pam.bris.ac.uk/services/GAI/cytokine4.htm.〉
Pociot, F. et al. A TaqI polymorphisms in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur. J. Clin. Invest. 22, 396–402 (1992).
Santtila, S., Savinainen, K. & Hurme, M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand. J. Immunol. 47, 195–198 ( 1998).
Andus, T. et al. Imbalance of the interleukin 1 system in colonic mucosa—association with intestinal inflammation and interleukin 1 receptor antagonist genotype 2. Gut 41, 651–657 (1997).
Danis, V. A., Millington, M., Hyland, V. J. & Grennan, D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin. Exp. Immunol. 99, 303–310 (1995).
Tountas, N. A. et al. Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. Gastroenterology 117, 806–813 ( 1999).
El-Omar, E. M. et al. Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori. Gastroenterology 118, 22–30 (2000).
Chow, H. W. et al. Risk of stomach cancer in relation to consumption of cigarettes, alcohol, tea and coffee in Warsaw, Poland. Int. J. Cancer 81, 871–876 (1999).
Cox, A., Camp, N. J., Nicklin, M. J., Di Giovine, F. S. & Duff, G. W. An analysis of linkage disequilibrium in the interleukin-1 gene cluster, using a novel grouping method for multiallelic markers. Am. J. Hum. Genet. 62, 1180–1188 (1998).
Stockbruegger, R. W. et al. Pernicious anaemia, intragastric bacterial overgrowth, and possible consequences. Scand. J. Gastroenterol. 19, 355–364 (1984).
Ruiz, B. et al. Vitamin C concentration in gastric juice before and after anti- Helicobacter pylori treatment. Am. J. Gastroenterol. 89, 533–539 (1994).
Carrington, M. et al. Typing of HLA-DQA1 and DQB1 using DNA single-strand conformation polymorphism. Hum. Immunol. 33, 208– 212 (1992).
Yu, C. R. et al. Differential utilization of Janus kinase-signal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-alpha. J. Immunol. 157 , 126–137 (1996).
Royall, R. M. Model robust confidence intervals using maximum likelihood estimators. Int. Stat. Rev. 54, 221–226 (1986).
Acknowledgements
We thank A. Goldstein and N. Chatterjee for advice on genetic and statistical issues, N. Dunlap for technical assistance, D. Gillen for help with subject recruitment and J. Goedert for suggestions. E.M.E. received a European Helicobacter pylori Study Group Research Fellowship from the Digestive Disorders Foundation, UK. This project was partly funded by the National Cancer Institute, National Institutes of Health, USA.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
El-Omar, E., Carrington, M., Chow, WH. et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404, 398–402 (2000). https://doi.org/10.1038/35006081
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/35006081
This article is cited by
-
Paracrine activin B-NF-κB signaling shapes an inflammatory tumor microenvironment in gastric cancer via fibroblast reprogramming
Journal of Experimental & Clinical Cancer Research (2023)
-
Interleukin 10 rs1800896 and interleukin 1B rs16944 polymorphisms and the risk of cervical cancer
Wiener Medizinische Wochenschrift (2023)
-
Association between interleuleukin-1β polymorphism (rs16944) and biomarkers levels in Iraqi patients with prostate cancer
Molecular Biology Reports (2023)
-
Investigating the relationship between the VNTR variant of the interleukin-1 receptor antagonist gene and coronary in-stent restenosis
Molecular Biology Reports (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.